PML in a patient treated with fumaric acid

New England Journal of Medicine

Volumn 368, Issue 17, 2013, Pages 1657-1658

  Ermis, Ummehan ^a   Weis, Joachim ^a   Schulz, Jörg B ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ETRETIN; FUMARIC ACID; FUMARIC ACID DIMETHYL ESTER; FUMARIC ACID ETHYL ESTER; GLUCOCORTICOID; MEFLOQUINE; METHOTREXATE; METHYLPREDNISOLONE; MIRTAZAPINE;

AGED; BRAIN BIOPSY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CORTICAL SENSORY APHASIA; DIFFERENTIAL DIAGNOSIS; DRUG WITHDRAWAL; HUMAN; HUMAN CELL; IMAGE ENHANCEMENT; IMMUNE DEFICIENCY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNOPHENOTYPING; JC VIRUS; LETTER; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; LONG TERM CARE; LYMPHOCYTE COUNT; LYMPHOCYTOPENIA; MALE; MONOTHERAPY; NEUROPATHOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; PARANEOPLASTIC SYNDROME; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PSORIASIS; VIRUS LOAD;

EID: 84876539679     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1211805     Document Type: Letter

References (3)

1. Harries MJ, Chalmers RJG, Griffiths CEM. Fumaric acid esters for severe psoriasis: a retrospective review of 58 cases. Br J Dermatol 2005;153:549-51. (Pubitemid 41248211)
2. Schröder A, Lee DH, Hellwig K, Lukas C, Linker RA, Gold R. Successful management of natalizumab-associated progressive multifocal leukoencephalopathy and immune reconstitution syndrome in a patient with multiple sclerosis. Arch Neurol 2010;67:1391-4.
3. Bloomgren G, Richman S, Hotermans C, et al. Risk of natal-izumab- associated progressive multifocal leukoencephalopathy. N Engl J Med 2012;366:1870-80.